Health Economic Data On The Medicines Company’s Infectious Disease And Cardiology Portfolios To Be Presented At The 17th Annual European Congress Of The International Society For Pharmacoeconomics And Outcomes Research (ISPOR)

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced that data from two health economics analyses will be presented at the 17th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) being held in Amsterdam, November 8-12. The abstracts involve analyses from two core areas of hospital focus for The Medicines Company: serious infectious disease care and acute cardiovascular care.

Help employers find you! Check out all the jobs and post your resume.